Table 1. Participant demographics.
Characteristic | Total Participants (n = 67) | Inf- and S-IgG- (n = 12) | Inf+ and S-IgG- (n = 17) | Inf+ and S-IgG+ (n = 38) |
---|---|---|---|---|
Age, Mdn (IQR) | 29.9 (24.8–38.0) | 29.7 (28.1–50.5) | 32.0 (27.5–35.5) | 29.0 (23.5–37.5) |
Gender, n(%) | ||||
Female | 18 (26.9%) | 6 (50%) | 1 (5.9%) | 11 (28.9%) |
Male | 46 (68.7%) | 6 (50%) | 14 (82.4%) | 26 (68.4%) |
Unknown# | 3 (4.5%) | 2 (11.8%) | 1 (2.6%) |
#Gender was not captured in 3 participants
This table presents the characteristics of the overall study population, which consisted of 67 individuals. These individuals were further categorized based on their infection and serological status into three groups: Inf- and S-IgG- (n = 12) as individuals who tested negative for infection and were also negative for the presence of specific IgG antibodies against the pathogen; Inf+ and S-IgG- (n = 17) as individuals who tested positive for infection but were negative for specific IgG antibodies against the pathogen, and Inf+ and S-IgG+ (n = 38) as Individuals who tested positive for infection and were also positive for specific IgG antibodies against the pathogen.